Cabiaux V, Phalipon A, Wattiez R, Falmagne P, Ruysschaert J M, Kaczorek M
Laboratoire de Chimie Physique des Macromolécules aux Interfaces, Université Libre de Bruxelles, Belgium.
Mol Microbiol. 1988 May;2(3):339-46. doi: 10.1111/j.1365-2958.1988.tb00037.x.
The toxB gene of Corynebacterium diphtheriae bacteriophage beta encoding the B fragment of diphtheria toxin was cloned into an inducible expression vector. When expressed in Escherichia coli, fragment B was not proteolysed and was indistinguishable, by immunological criteria, from wild-type C. diphtheriae-derived fragment B. Soluble fragment B was partially purified from the cytoplasm by saline precipitation steps and was shown to compete with the wild-type diphtheria toxin for binding to receptors of sensitive eukaryotic cells. A complete diphtheria toxin was reconstituted by formation of the disulphide bridge between purified fragment A and recombinant fragment B, which migrates at the expected Mr on Western blots and which was able to block protein synthesis by ADP-ribosylation of elongation factor-2, thereby indicating that the recombinant fragment B had retained its biological activity.
将编码白喉毒素B片段的白喉棒状杆菌噬菌体β的toxB基因克隆到一个可诱导表达载体中。当在大肠杆菌中表达时,B片段未被蛋白酶水解,并且根据免疫学标准,与野生型白喉棒状杆菌来源的B片段无法区分。通过盐沉淀步骤从细胞质中部分纯化出可溶性B片段,结果表明它能与野生型白喉毒素竞争结合敏感真核细胞的受体。通过在纯化的A片段和重组B片段之间形成二硫键,重构出完整的白喉毒素,该重组毒素在蛋白质印迹上以预期的相对分子质量迁移,并且能够通过对延伸因子2进行ADP核糖基化来阻断蛋白质合成,从而表明重组B片段保留了其生物学活性。